Shanghai Serum Bio-Technology Co. Ltd. A
Shanghai Serum Bio-Technology Co., Ltd. engages in the research, development, production, operation, and sales of antitoxin and antiserum products in China. It offers equine anti-tetanus immunoglobulin, anti-venin, and anti-rabies serum products. The company was founded in 1999 and is based in Shanghai, China.
Market Cap & Net Worth: Shanghai Serum Bio-Technology Co. Ltd. A (688163)
Shanghai Serum Bio-Technology Co. Ltd. A (SHG:688163) has a market capitalization of $354.43 Million (CN¥2.60 Billion) as of March 19, 2026. Listed on the SHG stock exchange, this China-based company holds position #16638 globally and #4397 in its home market, demonstrating a 2.65% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Shanghai Serum Bio-Technology Co. Ltd. A's stock price CN¥24.03 by its total outstanding shares 108220000 (108.22 Million).
Shanghai Serum Bio-Technology Co. Ltd. A Market Cap History: 2022 to 2026
Shanghai Serum Bio-Technology Co. Ltd. A's market capitalization history from 2022 to 2026. Data shows change from $294.66 Million to $354.43 Million (-16.99% CAGR).
Shanghai Serum Bio-Technology Co. Ltd. A Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Shanghai Serum Bio-Technology Co. Ltd. A's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.33x
Shanghai Serum Bio-Technology Co. Ltd. A's market cap is 1.33 times its annual revenue
1728.56x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
5.85x
Shanghai Serum Bio-Technology Co. Ltd. A's market cap is 5.85 times its annual earnings
0.11x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $294.66 Million | $174.22 Million | $64.20 Million | 1.69x | 4.59x |
| 2023 | $288.14 Million | $190.14 Million | $38.77 Million | 1.52x | 7.43x |
| 2024 | $259.00 Million | $194.92 Million | $44.29 Million | 1.33x | 5.85x |
Competitor Companies of 688163 by Market Capitalization
Companies near Shanghai Serum Bio-Technology Co. Ltd. A in the global market cap rankings as of March 19, 2026.
Key companies related to Shanghai Serum Bio-Technology Co. Ltd. A by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Shanghai Serum Bio-Technology Co. Ltd. A Historical Marketcap From 2022 to 2026
Between 2022 and today, Shanghai Serum Bio-Technology Co. Ltd. A's market cap moved from $294.66 Million to $ 354.43 Million, with a yearly change of -16.99%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥354.43 Million | +10.38% |
| 2025 | CN¥321.09 Million | +23.97% |
| 2024 | CN¥259.00 Million | -10.11% |
| 2023 | CN¥288.14 Million | -2.21% |
| 2022 | CN¥294.66 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Shanghai Serum Bio-Technology Co. Ltd. A was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $354.43 Million USD |
| MoneyControl | $354.43 Million USD |
| MarketWatch | $354.43 Million USD |
| marketcap.company | $354.43 Million USD |
| Reuters | $354.43 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.